Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Nutriband stock

Learn how to easily invest in Nutriband stock.

Drug delivery company Nutriband is conducting an offering of units comprised of one share of common stock and one warrant exercisable for one share of common stock.

The offering is contingent upon the approval of Nutriband's application for listing on the Nasdaq under the ticker symbol NTRB.

The stock is currently listed on the Over-the-Counter Markets under the same symbol.

How to buy shares in Nutriband

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NTRB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Nutriband stock price (NASDAQ: NTRB)

Use our graph to track the performance of NTRB stocks over time.

Nutriband shares at a glance

Information last updated 2022-07-04.
Latest market close$4.08
52-week range$2.81 - $15.00
50-day moving average $4.02
200-day moving average $5.01
Wall St. target price$14.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.94

Buy Nutriband shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Nutriband stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Nutriband price performance over time

Historical closes compared with the close of $4.08 from 2022-07-01

1 week (2022-06-28) -6.21%
1 month (2022-06-03) 1.37%
3 months (2022-04-05) -22.87%
6 months (2022-01-05) -41.63%
1 year (2021-07-02) -62.91%
2 years (2020-07-02) -60.20%
3 years (2019-07-02) 8
5 years (2017-07-01) N/A

Nutriband financials

Revenue TTM $1.5 million
Gross profit TTM $504,310
Return on assets TTM -23.85%
Return on equity TTM -69.26%
Profit margin 0%
Book value $1.42
Market capitalisation $32 million

TTM: trailing 12 months

Nutriband share dividends

We're not expecting Nutriband to pay a dividend over the next 12 months.

You may also wish to consider:

Have Nutriband's shares ever split?

Nutriband's shares were split on a 1:4 basis on 23 July 2019. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Nutriband shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Nutriband shares which in turn could have impacted Nutriband's share price.

Nutriband share price volatility

Over the last 12 months, Nutriband's shares have ranged in value from as little as $2.81 up to $15. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nutriband's is -0.5681. This would suggest that Nutriband's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Nutriband has bucked the trend.

To put Nutriband's beta into context you can compare it against those of similar companies.

Nutriband overview

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices.

Frequently asked questions

What percentage of Nutriband is owned by insiders or institutions?
Currently 30.157% of Nutriband shares are held by insiders and 1.588% by institutions.
How many people work for Nutriband?
Latest data suggests 13 work at Nutriband.
When does the fiscal year end for Nutriband?
Nutriband's fiscal year ends in January.
Where is Nutriband based?
Nutriband's address is: 121 South Orange Avenue, Orlando, FL, United States, 32801
What is Nutriband's ISIN number?
Nutriband's international securities identification number is: US67092M2089
What is Nutriband's CUSIP number?
Nutriband's Committee on Uniform Securities Identification Procedures number is: 67092M109

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site